Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
acquiror, adulterated, allot, Aspiring, Astra, Bentley, BICR, biopsy, biosafety, blinded, Bootcamp, breast, carcinoma, colorectal, CPA, customary, default, Depositary, developmental, discharging, divest, driven, duly, Eisai, elapsed, empowered, England, Eric, exacerbated, exit, FDIC, FDORA, fifteen, gave, Gemini, hour, IBC, immediatly, indenture, intentionally, IRA, issuable, ix, lawfully, lese, lifestyle, lump, MAGE, markedly, merged, Merrimack, multiplied, myeloid, Neogene, network, Occasionally, OS, OTAT, OTP, pancreatic, pendency, PFS, phenotype, PRAME, Predominately, preeminent, reallocate, receivership, reclassification, recovery, redosing, refocused, refrain, refund, renal, reorganization, repay, reprioritization, Rescue, retitling, revolving, Signature, Silicon, spouse, stolen, strike, student, style, subsidiary, Sullivan, Super, swept, thirteen, tighter, topline, triple, Triplet, troubled, tuition, underway, undrawn, unexercised, unfit, uninsured, unrestricted, Valley, viii, voluntarily, wage, whistleblower, workload, workshop
Removed:
aiming, allogeneic, Bipartisan, children, closer, contracted, crispr, deleting, dispensed, DSCA, DSCSA, escape, expired, format, hub, Ian, illegitimate, implanted, inhaled, injected, instilled, leverage, marketplace, Maxcyte, Mayur, methodology, Miltenyi, module, nurse, PDMA, poverty, presence, relapse, resignation, retrospective, selectively, Somaiya, Stevenage, stratified, Trump, validated, validation
Filing tables
Filing exhibits
Related press release
TCRR similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-236965, 333-252244 and 333-254355) on Form S-3 and (Nos. 333-229691, 333-237481, 333-254354 and 333-263770) on Form S-8 of our report dated March 23, 2023, with respect to the consolidated financial statements of TCR2 Therapeutics Inc.
/s/ KPMG LLP
Boston, Massachusetts
March 23, 2023